Literature DB >> 7804799

Pathogenetic mechanisms of acute hepatic encephalopathy.

K D Mullen1, R Gacad.   

Abstract

With the advent of liver transplantation as an accepted therapy for end-stage liver disease, increasing numbers of patients with severe hepatic dysfunction require ICU stabilization and treatment of associated complications. Of these, acute hepatic encephalopathy remains an important cause of morbidity and mortality. We review recent findings concerning interactions between the damaged liver and the brain that may have direct clinical implications in the management of hepatic encephalopathy in the critically ill.

Entities:  

Mesh:

Year:  1994        PMID: 7804799

Source DB:  PubMed          Journal:  New Horiz        ISSN: 1063-7389


  2 in total

1.  Role of carnitine in disease.

Authors:  Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark Dp Willcox; Qian Garrett
Journal:  Nutr Metab (Lond)       Date:  2010-04-16       Impact factor: 4.169

2.  Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.

Authors:  Mariano Malaguarnera; Maria Pia Gargante; Erika Cristaldi; Marco Vacante; Corrado Risino; Lisa Cammalleri; Giovanni Pennisi; Liborio Rampello
Journal:  Dig Dis Sci       Date:  2008-03-21       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.